Arrowstreet Capital Limited Partnership Sells 142,121 Shares of Amdocs Limited $DOX

Arrowstreet Capital Limited Partnership lowered its position in Amdocs Limited (NASDAQ:DOX) by 21.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 534,391 shares of the technology company’s stock after selling 142,121 shares during the quarter. Arrowstreet Capital Limited Partnership’s holdings in Amdocs were worth $48,758,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Alyeska Investment Group L.P. lifted its holdings in shares of Amdocs by 38.6% in the 1st quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company’s stock worth $213,174,000 after acquiring an additional 648,693 shares during the last quarter. American Century Companies Inc. raised its position in Amdocs by 23.5% in the 1st quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company’s stock worth $205,219,000 after purchasing an additional 426,911 shares during the period. Nuveen LLC bought a new stake in Amdocs in the first quarter worth $36,921,000. AQR Capital Management LLC boosted its position in Amdocs by 43.0% during the first quarter. AQR Capital Management LLC now owns 955,158 shares of the technology company’s stock valued at $86,719,000 after buying an additional 287,243 shares during the period. Finally, Nordea Investment Management AB boosted its position in Amdocs by 18.0% during the second quarter. Nordea Investment Management AB now owns 1,879,023 shares of the technology company’s stock valued at $170,803,000 after buying an additional 287,235 shares during the period. 92.02% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

DOX has been the subject of a number of recent research reports. Bank of America lowered their target price on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research note on Wednesday, November 12th. Stifel Nicolaus decreased their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Wall Street Zen downgraded Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a report on Thursday, October 30th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $97.00.

Amdocs Trading Up 0.8%

NASDAQ:DOX opened at $77.07 on Friday. The company has a 50-day moving average price of $80.59 and a 200-day moving average price of $85.77. The stock has a market cap of $8.70 billion, a price-to-earnings ratio of 15.26, a P/E/G ratio of 1.28 and a beta of 0.43. The company has a current ratio of 1.17, a quick ratio of 1.22 and a debt-to-equity ratio of 0.23. Amdocs Limited has a 12 month low of $74.32 and a 12 month high of $95.41.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, November 11th. The technology company reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.82 by $0.01. Amdocs had a net margin of 12.46% and a return on equity of 19.78%. The company had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.15 billion. During the same quarter in the previous year, the company earned $1.70 earnings per share. Amdocs’s quarterly revenue was down 9.0% on a year-over-year basis. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS and its Q1 2026 guidance at 1.730-1.790 EPS. Equities analysts predict that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be paid a $0.527 dividend. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date is Wednesday, December 31st. Amdocs’s dividend payout ratio (DPR) is presently 41.78%.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.